Chronic condition

$122.5 Million Healthcare Transformation Grant Launches Center for Better Aging

Retrieved on: 
Thursday, March 28, 2024
Community, LDS Family Services, Relaxation, Health equity, Patient, Stroke, City, Health care, Life expectancy, Chronic condition, Patient safety, IDPH, Ageing, Practitioner, Comprehension, Partnership, Risk, Diabetes, Emergency, American College, Social, Longevity, Knowledge, Hospital, University, CBA, HFS, Health, Public health, Chicago State University, Patient safety organization, Heart, Physician, Accreditation, Nursing

CHICAGO, March 28, 2024 /PRNewswire/ -- A one-of-a-kind healthcare collaborative, the Center for Better Aging (CBA) located at St. Bernard Hospital, opens in July with a health equity mandate to serve the growing 50+ population on Chicago's Greater South Side. 

Key Points: 
  • "A whole-person, collaborative approach will be vital to closing the life expectancy gap in the greater South Side community," said Center for Better Aging Executive Director Estrelitta Harmon .
  • CBA partners will elevate the standard of aging adult care and focus on what matters to each patient."
  • St. Bernard Hospital is the lead partner in securing a $122.5 million grant from the Illinois Department of Healthcare and Family Services to fund the nonprofit CBA under the HFS Healthcare Transformation Collaboratives program.
  • HFS is excited to continue this partnership with the Center for Better Aging, as we work together to reduce disparities, better serve customers and ultimately improve health outcomes in South Side communities."

Contract Research Organization (CRO) Market size to grow by USD 63.35 billion from 2024-2028, Market Growth at 12.61% CAGR expected during the forecast period, Technavio

Retrieved on: 
Wednesday, March 20, 2024
ChromeOS, Software as a service, Science, Chronic condition, Infection, Laboratory, Clinical trial, European, USD, Regulation, Obesity, Biotechnology, Risk, Diabetes, CNS, DSM-IV codes, ROW, Contract research organization, Compound annual growth rate, TB, PPD, Central nervous system disease, Neurology, Medicine, Medication, Clinical, Science 37, Research, Acquisition, Cancer, Drug development, HIV/AIDS, DCT, Growth, Cardiology, Software, Messenger, Behavior, PPD, Inc., Malaria, Lung compliance, Fine chemical

By geography, the global contract research organization (cro) market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Key Points: 
  • By geography, the global contract research organization (cro) market is segmented into North America, Europe, Asia, and Rest of World (ROW).
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global contract research organization (cro) market.
  • Growth of the Contract Research Organization (CRO) Market industry across North America, Europe, Asia, and Rest of World (ROW)
    Gain instant access to 17,000+ market research reports.
  • The global mRNA synthesis raw material market size is estimated to grow by USD 776.45 million at a CAGR of 4.93% between 2023 and 2028.

AvevoRx Further Expands Midwest Service Area to Include Kansas, North Dakota

Retrieved on: 
Tuesday, March 12, 2024
Disability, Conditional sentence, Growth, Patient, News, Death, Chronic condition, Health Promotion International, CDC

GREENSBORO, N.C., March 12, 2024 /PRNewswire-PRWeb/ -- AvevoRx, a national, independent provider of specialty infusion pharmacy services, has expanded its Midwest service area to include Kansas and North Dakota, adding to its growing national footprint. The news follows the company's expansion into South Dakota, announced earlier this year. AvevoRx is now licensed to treat patients in 30 states nationwide, over 73 percent of the U.S. population.

Key Points: 
  • AvevoRx is now licensed to treat patients in 30 states nationwide, over 73 percent of the U.S. population.
  • As we grow, we establish new processes and operations built on our core principles of speed, service, and simplicity to help scale."
  • We are fortunate to be in a position of steadily growing our service area so we can do more for more people."
  • AvevoRx began as a startup in Greensboro, North Carolina, founded in 2021 by a team of industry veterans with 130 years of combined experience.

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

Retrieved on: 
Monday, March 11, 2024
Connect the dots, Health, Disability, Organization, Learning, Health equity, CKD, Risk, Education, Patient, Black, Dots, Death, American Diabetes Association, Chronic condition, RDS, Chronic kidney disease, DaVita Inc.

DENVER, March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD). The kick-off for this expanded effort coincides with National Kidney Month, a time when both organizations bolster efforts to increase kidney health awareness and education.

Key Points: 
  • Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month
    DENVER, March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD).
  • Chronic disease is the leading cause of death and disability in the United States.
  • [1] More than 38 million Americans are living with diabetes, and approximately one in three American adults with diabetes has CKD.
  • On March 26, DaVita dietitians will join the ADA for a live cooking class featuring a tasty diabetes- and kidney-friendly meal.

Global Metagenomic Market Research 2024-2028: A Game Changer in Diagnostics - New Technology Changes Viewpoint on Infections - ResearchAndMarkets.com

Retrieved on: 
Friday, March 1, 2024
Health Technology, Health, Medical Devices, Infection, Metagenomics, Chronic condition, Genetics, Genome, Genetic testing, Knowledge, Disease, Research report, Research, Cancer

The "Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User 2024 to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User 2024 to 2028" report has been added to ResearchAndMarkets.com's offering.
  • Learn all about it in this new research report.
  • This report looks at the technology, the applications, the users and the types of products that will be sold.
  • Get our research team working for you by ordering all, or a portion, of this comprehensive report.

Despite slowing growth and regulatory headwinds, Medicare Advantage enrollment remains strong and outlook positive

Retrieved on: 
Tuesday, March 5, 2024
Preferred provider organization, SNP, Special needs plan, United States Census Bureau, CMS, Chronic condition, Management, Medicare Advantage, Growth, FFS, American International Group, Medicare, Region, Optimism, CBSA, Health insurance

CHICAGO, March 5, 2024 /PRNewswire/ -- Chartis, a comprehensive healthcare advisory firm, today announced the release of its annual 2024 Medicare Advantage competitive enrollment report. This year's report is a collaboration between Chartis and HealthScape Advisors, A Chartis Company. Together, they help payers and providers manage transformational change in a rapidly evolving healthcare ecosystem that is increasingly defined by payer-provider convergence.

Key Points: 
  • This year's edition of the report shows that despite strong enrollment gains, market growth appears to be slowing.
  • The Medicare Advantage market grew by 1.7 million beneficiaries (+5.4%) in 2023, slowing down from the record growth of 2.7 million (+9.4%) in 2022.
  • This ongoing enrollment growth is fueled by an increasing senior market but is overshadowed by regulatory pressures, declining quality scores, and rising medical costs.
  • In addition to top-line enrollment statistics and executive sentiment, Chartis' 2024 Medicare Advantage report analyzed:
    Special Needs Plan (SNP) growth: SNP enrollment has surged, adding 1.2 million members.

Global Nanomedicine Market Report 2023-2028: United States Emerges as a Key Player

Retrieved on: 
Monday, February 26, 2024
Therapy, Incidence, Natural language processing, Merck, Regenerative medicine, Laboratory, Infection, Gilead Sciences, Nanostructure, Dendrimer, Chronic condition, Investment, Nanocarriers, Quality of life, Ageing, Growth, Johnson & Johnson, Conditional sentence, Government, World Health Organization, Urbanization, Nanotechnology, Geography, Prevalence, Safety, Nanoparticle, Attention, Administration, GE HealthCare, Liposome, Nanomaterials, Abbott Laboratories, Organization, Medicine, Notifiable disease, Diagnosis, Machine learning, Deep learning, Amgen, Research, Cancer

DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Nanomedicine Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Nanomedicine Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The nanomedicine market size is still developing, with ongoing research and development aimed at increasing nanomedicine products' efficacy, safety, and scalability.
  • Due to significant investments made by research facilities, pharmaceutical companies, and the government, the United States has a sizable nanomedicine market revenue share.
  • Key Players in the Nanomedicine Market:
    Abbott Laboratories: Nanomaterials, diagnostics, and medical equipment are the primary areas of focus at Abbott Laboratories.

Health Advocate Selects Reperio Health as Partner for Comprehensive, At-Home Biometric Health Screenings, Reaching Clients and Members Nationwide

Retrieved on: 
Tuesday, February 6, 2024
General Health, Health, Health Technology, Telemedicine, Virtual Medicine, Managed Care, Partnership, Population health, Workplace, Nursing, Health Advocate, Chronic condition, Organization

“With Reperio, our clients have the ability to fully-digitize their biometric health screening experience.

Key Points: 
  • “With Reperio, our clients have the ability to fully-digitize their biometric health screening experience.
  • Since 2001, Health Advocate has delivered services that reduce healthcare costs, support businesses, enrich the workplace, and empower healthy change.
  • The partnership between Reperio and Health Advocate harkens to the companies’ shared commitment to make healthcare easier for organizations, their employees, and their employees’ family members.
  • “We continue our commitment to affect population health for the better through our partnership with Health Advocate,” said Travis Rush, co-founder and CEO at Reperio.

The Rockefeller Foundation to Increase Investment in U.S. Food is Medicine Solutions to $100 Million

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Growth, Human services, Rockefeller Foundation, Research, Chronic condition, Cardiovascular disease, Patient, HHS, Death, Disability, Diabetes, Veteran, Health, American Heart Association, Organization, Pharmaceutical industry

NEW YORK, Jan. 31, 2024 /PRNewswire/ -- The Rockefeller Foundation announced that it will invest an additional USD $80 million over the next five years to advance Food is Medicine programs in the United States. Today's announcement, which increases The Rockefeller Foundation's total Food is Medicine commitment to more than $100 million since 2019, aims to improve domestic health outcomes where diet-related diseases, like diabetes and cardiovascular disease, are a principal driver of deaths, disability, and health care costs. It also marks the start of a new partnership with the U.S. Department of Health and Human Services (HHS) to accelerate the adoption of Food is Medicine in health systems.

Key Points: 
  • It also marks the start of a new partnership with the U.S. Department of Health and Human Services (HHS) to accelerate the adoption of Food is Medicine in health systems.
  • Food is Medicine programs in communities around the country have demonstrated promise to address both outcomes.
  • The American Heart Association announced the first 19 Food is Medicine research projects on January 24, 2024.
  • Educating for better policies to accelerate action and build coalitions to create demand for an expansion of Food Is Medicine interventions, especially for high-need populations.

Healthcare Cloud Computing Market Analysis and Forecast: Emphasizing Application, Deployment, and End User Growth till 2033

Retrieved on: 
Wednesday, January 24, 2024
Cloud, Competitive landscape, Cloud computing, Data management, Service model, Component, Research report, Chronic condition, IBM, Microsoft, Health, Prevalence, Growth

The global healthcare landscape is on the cusp of a digital revolution, with the latest comprehensive analysis highlighting the rapid growth of the healthcare cloud computing market.

Key Points: 
  • The global healthcare landscape is on the cusp of a digital revolution, with the latest comprehensive analysis highlighting the rapid growth of the healthcare cloud computing market.
  • Intricately designed to cater to various stakeholders, the new research report delineates the evolving facets of cloud technology applications within healthcare.
  • The integration of cloud computing in healthcare echoes the overarching need for superior data management and affordable IT frameworks.
  • The definitive prognostication provided in this extensive report illuminates the pathway for existing healthcare institutions and startups to adapt and innovate, thereby influencing the outlook of global healthcare cloud computing market through 2033.